why choose us

First received: September 26, 2024

Clinical Trial: Neoadjuvant Toripalimab Plus Docetaxel and Carboplatin in Patients With Localized TNBC (NeoTOP)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: A Single-Arm Phase II Trial of Neoadjuvant Toripalimab, Docetaxel, Plus Carboplatin in Patients With Localized Triple-Negative Breast Cancer

Brief Summary: This study aims to investigate efficacy and safety of neoadjuvant toripalimab plus docetaxel and carboplatin in patients with localized triple-negative breast cancer.

Read more